Public Affairs & Fundraising

Ainsley Advisory Group partners with healthcare leaders and nonprofits to navigate complex private and public-sector environments and secure the resources needed for transformational impact. Our team blends policy expertise with strategic fundraising execution—helping clients shape their narrative, influence key stakeholders, and unlock capital. We ensure our clients are positioned to lead in moments of change.

Schedule a Consultation

How Can AI Benefit the Public Affairs & Fundraising space?

AI can streamline research, donor targeting, and outreach so teams spend less time gathering information and more time building meaningful relationships. It can analyze patterns across thousands of data points to identify the issues people care about and predict who is most likely to engage or give. AI also personalizes messaging at scale, helping organizations communicate the right story to the right audience at the right time. Ultimately, it frees public affairs and fundraising teams to focus on high-impact strategy instead of repetitive admin work.

Healthcare AI Strategy consultants gathered around a tablet discussing The Red Zone from Ainsley Advisory Group

Working with the Ainsley Advisory Group has been a game changer. They didn’t just offer strategic guidance—they opened doors to the right people at the right time. The introductions they facilitated directly accelerated our growth and helped us scale in ways that would have taken much longer on our own. We’re incredibly grateful for their partnership.

Olivier Tak

March AI CEO

Dr. MacLean and her team are tireless advocates for bringing more innovation into the healthcare system for the benefit of patients and doctors. The rollout of a deeply technical and innovative product can be complex and Ainsley has proven to be highly effective at identifying and removing barriers on the path to delivery. It is an absolute pleasure to be working with their team!

Tobias Rijken, MSc

Co-founder & Chief Technology Officer, Kheiron Medical Technologies

I have had the pleasure of working with Dr. MacLean and have been so impressed with her as a leader, innovator, and colleague. Her passion to change healthcare using cutting edge technology while understanding how to balance rapid adoption with thoughtful integration is incredibly unique. I would highly recommend her to any healthcare organization that is looking to take the advances in AI and incorporate them into improving care delivery, outcomes, and experience for individuals.

Lisa Shah, MD

Chief Medical Officer & Executive Vice President, Twin Health
President, Twin Medical Group

Dr. MacLean has consistently demonstrated a steadfast commitment to clinical excellence and member-focused outcomes. Her responsiveness, adaptability, and focus on building bridges between technology and patient care leaders have inspired colleagues across the KP enterprise. We are forever grateful for her contributions and the legacy of compassionate, forward-thinking leadership.

Matthew Reynolds

Experienced Healthcare IT Executive

At a healthcare conference Dr. MacLean delivered an inspiring keynote address. She articulated a compelling vision of how AI can enhance patient care, improve diagnostic accuracy, and streamline healthcare processes. Her expertise extends beyond theory – as evident in her work at KP that has led to the implementation of innovative AI tools that have tangibly improved patient outcomes. Her insights are invaluable for anyone looking to understand the future of medicine and the transformative potential of AI in healthcare.

Savitha Srinivasan

Managing Director, VC Relations & Partnerships, Trace3

Dr. MacLean is the leader of an all-star radiology team. Under her leadership, the department continues to implement changes for better service quality, better member satisfaction and amazing patient care. Her enthusiasm for medicine and focus on patient care has earned her tremendous respect within our organization and in the community. She is a pleasure to work with.

Robert Hickey

Chief Executive Officer & Consultant, Physician Loan Directory & Bere Island Consulting

I’ve had the distinct pleasure of getting to know Ainsley, whose exceptional ability to communicate complex concepts and visionary leadership inspired teams across KP and those fortunate enough to hear their accomplishments. Ainsley’s profound ability to convey AI’s potential to revolutionize clinical care and enhance physicians’ daily experiences is unusual and compelling. As a natural leader, Ainsley’s passion and depth make her an invaluable asset to any forward-thinking organization.

Julie Vaughan Murchinson

Digital Health Driver, Investor & Operating Executive

AI Advising Services

We provide strategic advising services tailored to the needs of venture capital firms, family offices, biotech and pharmaceutical companies, government agencies, startups, and healthcare organizations. Our expertise empowers clients to harness AI-driven innovations, driving transformation across the healthcare landscape with precision, efficiency, and impact.

View All Services

AI for Venture Capital

Our physician-led team guides venture capital partners through healthcare AI investment decisions with proprietary evaluation frameworks and deep regulatory expertise that separates viable innovations from costly missteps.

View Service

AI for Startups

We accelerate portfolio company success by bridging the gap between healthcare innovation and real-world implementation, providing regulatory strategy, clinical validation, and go-to-market execution that drives scalable growth.

View Service

AI for Health Systems

Our team transforms health systems through strategic AI implementation that improves patient outcomes and operational efficiency, leveraging proven experience from large-scale deployments across millions of patients.

View Service

AI for BioPharma

We guide pharmaceutical and biotech companies in leveraging AI for drug discovery, clinical trials, and regulatory pathways, combining deep clinical expertise with strategic execution that accelerates time-to-market.